Status and phase
Conditions
Treatments
About
This study is an open-label, multicenter Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics and efficacy of HRS-3738 in patients with recurrent and refractory Non-Hodgkin's lymphoma and multiple myeloma.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
198 participants in 1 patient group
Loading...
Central trial contact
Wenjun Mao
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal